MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Scholar Rock Holding Corporation (NASDAQ:SRRK)*
Organization & Developments: Scholar Rock Holding
Parents
Scholar Rock Holding Corporation (NASDAQ:SRRK)*
Children
2018: Gilead Doubles Down On Its NASH Pipeline With $1.5B Deal_Scholar Rock Holding Corporation_seekingalpha.com
2023: Scholar Rock: SMA Data Readout In 2024 Makes This Worth A Look
2024: Scholar Rock scores with ‘surprise’ success in SMA ( spinal muscular atrophy) drug study
2024: Scholar Rock: SMA Program Strides Forward With Positive Clinical Data
2025: Scholar Rock Holding: Upcoming Milestone Approaches (NASDAQ:SRRK)
2025: Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data_ seekingalpha.com
4497612-scholar-rock-lead-drug-declined-by-fda?mailingid=41684332&messageid=2900&serial=41684332.1150&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=41684332
Jumps
Finance & Acquisition: Scholar Rock Holding Corporation
Key People: Scholar Rock Holding